Find A Physician
Return to Leukemia and Myeloproliferative Disease Center Overview
More on Leukemia and Myeloproliferative Disease Center
Hospital News
Return to Leukemia and Myeloproliferative Disease Center Overview
More on Leukemia and Myeloproliferative Disease Center
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Clinical Trial for a Novel Multiple Myeloma Vaccine Begins at New York Weill Cornell Medical Center
- Columbia Receives $3 Million Award From Pediatric Cancer Foundation for New Research Laboratory
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma
- Coping With Chronic Cancer Pain
- Do Heart Disease and Cancer Have a Common Genetic Link?
- Dr. Selina Chen-Kiang Honored as Researcher of the Year by the Leukemia and Lymphoma Society
- Gleevec May Be Effective Against a Second Blood Disease, According to Study To Be Presented at Hematology Meeting
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Helping Parents Do the Right Thing: New Guidelines on Umbilical Cord Blood Banking
- Integrative Therapies Program for Children with Cancer at Morgan Stanley Children's Hospital of NewYork-Presbyterian Receives Gift Commitment from Origins Natural Resources
- Latest Findings Presented at Second International Symposium on Pediatric Non-Hodgkin's Lymphoma
- Message to the Elderly: It's Never Too Late to Prevent Illness!
- Multiple Myeloma Oral Therapy REVLIMID Approved by FDA
- New Anti-Leukemia Drug Significantly Improves Survival Even for Patients With Late-Stage Disease, Study Finds
- New Book by Weill Cornell Psychiatrist Offers Insight and Hope for "Surviving Cancer Emotionally"
- NewYork-Presbyterian/Weill Cornell Creates World-Class Cancer Center
- NewYork-Presbyterian/Weill Cornell Multiple Myeloma Program Begins Clinical Trial of Promising New Chemotherapy Cocktail with Revlimid
- NewYork-Presbyterian Hospital/Columbia University Medical Center Physician-Scientists Present at American Society of Clinical Oncology 44th Annual Meeting
- NewYork-Presbyterian Hospital's Weill Cornell Medical Center Announces Preliminary Lung Cancer Data Involving Patients Treated With Arthritis Medication
- NewYork-Presbyterian Hospital and Columbia University Medical Center Physicians-Scientists Present Latest Cancer Findings at American Society of Hematology Meeting
- NewYork-Presbyterian Hospital Oncologists, from Columbia, Weill Cornell, Co-Lead World's Largest Lymphoma Forum for Patients
- One of the Nation's Largest Portfolios of New Lymphoma Therapies Targets Diverse and Difficult Cancer
- The Seventh Issue of Cancer Prevention Has Arrived!
- Tumor Size Predicts Survival in Most Common Type of Lung Cancer
- Two Novel Biologics Studied for Multiple Myeloma
- Weill Cornell Medical College Wins $7.5 Million Grant From Leukemia Society To Study Multiple Myeloma
- Weill Cornell Physician-Scientists Present Latest Cancer and Blood Findings at American Society of Hematology (ASH) Meeting
- Weill Cornell Researchers Report "Encouraging" Results with First Combination Antibody Therapy for Lymphoma
Research and Clinical Trials
Return to Leukemia and Myeloproliferative Disease Center Overview
More on Leukemia and Myeloproliferative Disease Center
Health Library
Return to Leukemia and Myeloproliferative Disease Center Overview
More on Leukemia and Myeloproliferative Disease Center
- Acute Lymphocytic Leukemia
- Acute Myelogenous Leukemia
- Bone Marrow Transplantation
- Cancer: Overview of Diagnostic Procedures
- Cancer Overview
- Cancer Rehabilitation
- Cancer Treatment Protocols
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Cutaneous T-Cell Lymphoma
- Cytology
- External Beam Therapy
- Grading and Staging of Cancer
- Hodgkin's Disease
- Leukemia Overview
- Myeloma Bone Disease / Multiple Myeloma
- Non-Hodgkin's Lymphoma
Clinical Services
Return to Leukemia and Myeloproliferative Disease Center Overview
More on Leukemia and Myeloproliferative Disease Center
- Adult Bone Marrow Transplant
- Bladder Cancer
- Blood and Bone Marrow Transplant
- Blood Cancer
- Brain Cancer
- Center for Holistic Urology
- Center for Lymphoma and Myeloma
- Colon Cancer
- Early Lung Cancer Action Program
- Edward S. Harkness Eye Institute
- Esophageal Cancer
- Eye Cancer
- Gastrointestinal Cancer
- Gynecological Cancer
- Head and Neck Cancer
- Hematology (Blood Disorders)
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Mesothelioma
- Oncology (Cancer)
- Pancreatic and Biliary Cancer
- Pediatric Cancer
- Prostate Cancer
- Rectal Cancer
- Robert M. Ellsworth Ophthalmic Oncology Center
- Soft Tissue and Bone Cancer
- Spirit of Care Program
- Stomach Cancer
- Testicular Cancer
- Urologic Cancer
Leukemia and Myeloproliferative Disease Center
In March 2002, Weill Medical College of Cornell University received a grant from the Cancer Research and Treatment Fund to establish the Leukemia and Myeloproliferative Disease Center. The Center supports multidisciplinary basic research into the genetic and cellular causes of these diseases and the translation of research discoveries into new diagnostic and therapeutic modalities.
Hospital News
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Clinical Trial for a Novel Multiple Myeloma Vaccine Begins at New York Weill Cornell Medical Center
- Columbia Receives $3 Million Award From Pediatric Cancer Foundation for New Research Laboratory More
